SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Ajanta Pharma’s arm launches Montelukast IR tablets and Montelukast chewable tablets

03 Dec 2015 Evaluate

Ajanta Pharma’s subsidiary -- Ajanta Pharma USA, has launched Montelukast Sodium IR tablets (10mg) and Montelukast Sodium Chewable tablets (4mg & 5mg), generic versions of SINGULAIR Tablets and SINGULAIR Chewable tablets, respectively. The United States Food & Drug Administration (US FDA) approval extends the breadth of the Montelukast offerings from the company into three dosage forms (Immediate-Release Tablets, Chewable Tablets, and Oral Granules).

Montelukast IR tablets and Chewable tablets are part of an ever-growing portfolio that the company has developed for the US market. To date, the US FDA has granted the company’s five ANDA final approvals and two ANDA tentative approvals. An additional 19 ANDAs are pending approval from the US FDA.

Ajanta Pharma is a fully-integrated pharmaceutical company with global headquarters in Mumbai, India. Over 6,000 employees are engaged in developing, manufacturing and marketing of quality finished dosages across 35 countries. Its mission is to serve global healthcare needs through empathy, innovation and technology.

Ajanta Pharma Share Price

2790.15 -37.95 (-1.34%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×